TScan Therapeutics Inc

Explore TScan Therapeutics’ progress in T‑cell immunotherapy, its latest Nasdaq performance, and future growth prospects for investors.

TScan Therapeutics, Inc. is a pioneering biotech company developing innovative T cell therapies that harness the power of the human immune system to revolutionize patient care on a global scale.